Medigen Vaccine Biologics Market Cap

Medigen Vaccine Biologics has a market cap or net worth of 15.65 billion as of April 28, 2026. Its market cap has decreased by -1.35% in one year.

Market Cap

15.65B

Enterprise Value

14.16B

Revenue

613.17M

Ranking

n/a

PE Ratio

n/a

Stock Price

48.00

Market Cap Chart

Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 15.65B, an increase of 451.97%. That is a compound annual growth rate of 17.25%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	15.65B	26.09%
Dec 31, 2025	12.41B	4.72%
Dec 31, 2024	11.85B	-48.55%
Dec 29, 2023	23.04B	1.10%
Dec 30, 2022	22.78B	-64.20%
Dec 30, 2021	63.65B	192.75%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AP Biosciences	16.30B
Polaris Group	15.05B
EirGenix	13.95B
TaiMed Biologics	13.20B
Locus Cell	13.12B
Lumosa Therapeutics	21.10B
Sunmax Biotechnology	21.51B
Ever Supreme Bio Technology	11.43B

Market Cap Rankings